|
TOMM20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.73869984655096E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96409555286436E-11 |
| Normal-vs-Stage2 |
7.610100E-04 |
| Normal-vs-Stage3 |
1.363150E-01 |
| Normal-vs-Stage4 |
5.550600E-01 |
| Stage1-vs-Stage2 |
5.623000E-01 |
| Stage1-vs-Stage3 |
1.520370E-02 |
| Stage1-vs-Stage4 |
5.854300E-02 |
| Stage2-vs-Stage3 |
1.995620E-01 |
| Stage2-vs-Stage4 |
9.164200E-02 |
| Stage3-vs-Stage4 |
2.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75150000059077E-08 |
| Normal-vs-AfricanAmerican |
5.83720000000287E-05 |
| Normal-vs-Asian |
1.069020E-01 |
| Caucasian-vs-AfricanAmerican |
8.950600E-01 |
| Caucasian-vs-Asian |
5.012600E-01 |
| AfricanAmerican-vs-Asian |
5.400600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0863976385167E-11 |
| Normal-vs-Female |
2.841600E-02 |
| Male-vs-Female |
1.475380E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.159500E-02 |
| Normal-vs-Extreme_Weight |
6.77179978758602E-10 |
| Normal-vs-Obese |
2.296000E-03 |
| Normal-vs-Extreme_Obese |
1.944410E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.609800E-02 |
| Normal_Weight-vs-Obese |
6.574600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.016100E-02 |
| Extreme_Weight-vs-Obese |
4.285900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.994800E-01 |
| Obese-vs-Extreme_Obese |
2.008000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.948800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.5311999999974E-05 |
| Normal-vs-Age(61-80Yrs) |
1.74430025978722E-10 |
| Normal-vs-Age(81-100Yrs) |
2.9401000523066E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.591600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.214800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.497700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.753700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.243400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.771830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.59792187762287E-13 |
| Normal-VS-Type2 PRCC |
2.217500E-02 |
| Normal-VS-KIRP CIMP |
8.169600E-01 |
| Normal-VS-Unclassified PRCC |
4.207700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.724800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.679600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.684200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.396600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.570200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.360400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.80110000142153E-08 |
| Normal-vs-N1 |
5.215800E-01 |
| Normal-vs-N2 |
3.013200E-01 |
| N0-vs-N1 |
9.681200E-03 |
| N0-vs-N2 |
4.206700E-04 |
| N1-vs-N2 |
4.977000E-01 |
|
|
